Top 10 Companies in the Global Pseudomonas Putida Market (2026): Key Players Driving Industrial Biotechnology

In Business Insights
January 29, 2026

The Global Pseudomonas Putida Market was valued at USD 91.3 million in 2025 and is projected to reach USD 154.2 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period. This robust growth is primarily fueled by the expanding applications of this versatile bacterium in bioremediation, sustainable chemical production, and agriculture, driven by stringent environmental regulations and a global shift towards bio-based solutions.

As industries worldwide intensify their focus on sustainability and circular economy principles, Pseudomonas Putida has emerged as a powerful microbial chassis for innovation. In this blog, we profile the Top 10 Companies in the Global Pseudomonas Putida Market—a dynamic mix of established biotechnology giants, chemical corporations, and specialized innovators shaping the future of industrial microbiology.


🔟 1. Novozymes A/S

Headquarters: Bagsværd, Denmark
Key Offering: Microbial Solutions, Enzymes, Bioagriculture Products

Novozymes is a global leader in biological solutions, leveraging its extensive expertise in microbiology to develop and commercialize Pseudomonas Putida-based products. The company utilizes this bacterium primarily for biocontrol agents in agriculture and specialized enzymes for industrial processes. Their advanced fermentation technologies and strong R&D focus position them at the forefront of the market.

Innovation Initiatives:

  • Pioneering microbial solutions for sustainable agriculture

  • Development of high-yield fermentation processes for P. putida strains

  • Strategic partnerships for bio-based chemical production

Download FREE Sample Report: Global Pseudomonas Putida Market – View in Detailed Research Report


9️⃣ 2. Royal DSM

Headquarters: Heerlen, Netherlands
Key Offering: Specialty Chemicals, Nutritional Products, Biomedical Materials

DSM employs Pseudomonas Putida as a key platform organism in its biotechnology division for producing bio-based chemicals and advanced materials. The company’s strong capabilities in metabolic engineering allow it to tailor P. putida strains for efficient production of complex molecules, catering to the pharmaceutical and materials science sectors.

Innovation Initiatives:

  • Metabolic engineering for sustainable chemical production

  • Focus on biomedical and high-value application development


8️⃣ 3. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Biochemicals, Crop Protection Products, Industrial Enzymes

BASF integrates Pseudomonas Putida into its extensive portfolio of bio-based solutions, particularly for agricultural applications and industrial biocatalysis. The company’s global scale and significant investment in R&D enable the development of effective P. putida strains for biopesticides and as catalysts in green chemistry processes.

Innovation Initiatives:

  • Development of biofertilizers and biopesticides

  • Application in green chemistry and sustainable manufacturing


7️⃣ 4. LanzaTech

Headquarters: Skokie, Illinois, USA
Key Offering: Carbon Capture and Transformation Technology, Sustainable Fuels & Chemicals

LanzaTech is a pioneer in gas fermentation technology and is exploring Pseudomonas Putida’s potential for converting waste carbon into valuable products. While renowned for its work with other microbes, the company’s innovative platform is adaptable, positioning it to leverage P. putida for producing sustainable chemicals from industrial waste gases.

Innovation Initiatives:

  • Carbon recycling technology platforms

  • Waste-to-value biochemical production

Download FREE Sample Report: Global Pseudomonas Putida Market – View in Detailed Research Report


6️⃣ 5. Mitsubishi Chemical Corporation

Headquarters: Tokyo, Japan
Key Offering: Performance Chemicals, Polymers, Healthcare Materials

Mitsubishi Chemical applies Pseudomonas Putida in its development of biodegradable polymers and specialty chemicals. The company’s focus on creating sustainable alternatives to conventional plastics has led to significant R&D in utilizing P. putida for producing polyhydroxyalkanoates (PHAs) and other bio-based materials.

Innovation Initiatives:

  • Bioplastic (PHA) production development

  • Advanced biorefinery concepts


5️⃣ 6. DuPont de Nemours, Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Industrial Biosciences, Specialty Materials, Safety Solutions

DuPont leverages its strong industrial biosciences division to harness Pseudomonas Putida for various applications, including environmental remediation and industrial enzyme production. The company’s expertise in microbial strain improvement and process optimization makes it a significant player in commercializing P. putida-based technologies.

Innovation Initiatives:

  • Strain engineering for enhanced performance

  • Bioremediation and waste treatment solutions


4️⃣ 7. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Specialty Chemicals, Health & Nutrition, Performance Materials

Evonik utilizes Pseudomonas Putida in its specialty chemicals and nutrition segments, focusing on producing amino acids, specialty surfactants, and other high-value compounds. The company’s commitment to white biotechnology drives its investment in optimizing P. putida strains for efficient bio-manufacturing.

Innovation Initiatives:

  • Bio-based specialty chemical production

  • Sustainable ingredient development for nutrition


3️⃣ 8. Ginkgo Bioworks

Headquarters: Boston, Massachusetts, USA
Key Offering: Cell Programming Services, Biomanufacturing Platforms

Ginkgo Bioworks offers advanced cell programming services and has extensively worked with Pseudomonas Putida as a versatile chassis organism for synthetic biology applications. The company’s platform enables the design of custom P. putida strains for partners across industries, from agriculture to pharmaceuticals.

Innovation Initiatives:

  • Strain design and optimization services

  • Platform for custom microbial development


2️⃣ 9. Codexis, Inc.

Headquarters: Redwood City, California, USA
Key Offering: Enzyme Engineering, Biocatalysis Solutions

Codexis specializes in engineering enzymes and microbial strains, including Pseudomonas Putida, for efficient biocatalytic processes in pharmaceutical and chemical manufacturing. The company’s protein engineering expertise allows it to enhance the capabilities of P. putida for specific industrial reactions.

Innovation Initiatives:

  • Enzyme engineering for biocatalysis

  • Pharmaceutical intermediate production


1️⃣ 10. Global Bioenergies

Headquarters: Evry, France
Key Offering: Renewable Hydrocarbons, Sustainable Chemistry Processes

Global Bioenergies develops processes for converting renewable resources into hydrocarbons and has explored Pseudomonas Putida for bio-isobutene and other drop-in bio-chemical production. The company’s focus on creating sustainable alternatives to petrochemicals aligns with the metabolic capabilities of P. putida.

Innovation Initiatives:

  • Renewable hydrocarbon production

  • Drop-in bio-chemical development

Get Full Report Here: Global Pseudomonas Putida Market – View in Detailed Research Report


🧪 Outlook: The Future of Pseudomonas Putida Applications Is Diversified and High-Value

The Pseudomonas Putida market is undergoing a significant transformation, evolving from niche environmental applications to a versatile platform for sustainable industrial biotechnology. While traditional uses in bioremediation remain important, the industry is increasingly investing in high-value applications across pharmaceuticals, agriculture, and specialty chemicals.

📈 Key Trends Shaping the Market:

  • Accelerated adoption in pharmaceutical intermediate synthesis

  • Growing demand for bio-based plastics and polymers

  • Expansion in sustainable agricultural solutions

  • Advancements in synthetic biology and strain engineering

Get Full Report Here: Global Pseudomonas Putida Market – View in Detailed Research Report

The companies listed above are not only commercializing existing Pseudomonas Putida technologies—they’re pioneering the next generation of sustainable bioprocesses that will define the future of industrial manufacturing.